Company Filing History:
Years Active: 2012-2023
Title: Veit Braun: Innovator in Antibody Preparation
Introduction
Veit Braun is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of medical science, particularly in the development of antibody preparations for treating viral infections. With a total of 7 patents, his work has the potential to impact medical treatments significantly.
Latest Patents
One of his latest patents focuses on methods of treating viral infections by administering an antibody preparation that comprises IgG, IgA, and IgM. This preparation is suitable for intravenous administration in humans and includes at least 5% IgM antibodies by weight of the total amount of antibodies. The preparation is derived from human plasma and exhibits specific complement-activating activity. In an in vitro assay with human serum, the antibody preparation generates substantially no C5a and/or substantially no C3a, indicating its potential for medical applications.
Another patent by Braun details an antibody preparation that is also suitable for intravenous administration in humans, comprising IgG, IgA, and at least 5% IgM antibodies. Similar to his previous work, this preparation is prepared from human plasma and has specific complement-activating activity, making it a promising candidate for medical use.
Career Highlights
Throughout his career, Veit Braun has worked with reputable companies such as Biotest AG and Biodics. His experience in these organizations has contributed to his expertise in the field of antibody preparations and their applications in medicine.
Collaborations
Veit Braun has collaborated with notable professionals in his field, including Dieter Rudnick and Oliver Maneg. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in antibody preparation.
Conclusion
Veit Braun's contributions to the field of medical science through his innovative antibody preparations demonstrate his commitment to advancing healthcare. His patents hold promise for future medical applications, potentially improving treatment options for viral infections.